MorphoSys, Lonza manufacturing agreement

Lonza Biologics (Slough, U.K.) will produce antibodies derived from HuCAL technology from MorphoSys (NMarkt:MOR). The five-year deal provides MOR with process development and manufacturing capacity fo...